title: Evaluation of a quantitative double ELISA strategy for confirmation and differentiation of HIV infection.
abstract: The current HIV pandemic is complicated by the spread of distinct types and subtypes of HIV. The currently used conventional diagnostic tests have shown limitations in the detection of antibodies against all HIV-1 subtypes, as demonstrated by recent identification of HIV-1 subtype O. To evaluate quantitatively the diagnostic potential of a double ELISA strategy for the detection and partial differentiation of HIV-1, HIV-1 subtype O and HIV-2 infections blood samples were examined at five different test centers: Blantyre, Malawi; Abidjan and Daloa, Ivory Coast; Yaoundé, Cameroon; Munich, Germany. All tests results, including ELISA extinction values and Western blot profiles, were forwarded to Munich for final interpretation. An indirect anti-HIV-1/2 ELISA and a competitive anti-HIV-1 ELISA were used in combination for the initial screening of blood specimens. All anti-HIV positive and anti-HIV negative samples were subjected to immunoblot analysis. Independent of the diversity of the extinction profiles, and of the test manufacturer, the quantitative evaluation of the ELISA extinction values could define two extinction areas with a 100% predictive value for HIV-1 seropositivity and HIV seronegativity; extinction values > 2 by the indirect ELISA and < 0.2 by the competitive ELISA for an anti-HIV-1 subtype A to I positive result; extinction values < 0.2 by the indirect ELISA and > 1.0 by the competitive ELISA for an anti-HIV negative result. Additionally, the quantitative evaluation of the extinction profile provides partial information on the HIV-1 subtype as far as the distinction in group M and group O is concerned. In conclusion, the quantitative evaluation of this double ELISA strategy can reduce the number of blood specimens that require additional confirmatory testing in developing countries and can be superior to the immunoblot method during early seroconversion.
authors.affiliation: Department of Infectious Diseases and Tropical Medicine, University of München, Germany.
authors.forename: T M
authors.initials: TM
authors.lastname: Rehle
authors.forename: P
authors.initials: P
authors.lastname: Mattke
authors.forename: G N
authors.initials: GN
authors.lastname: Liomba
authors.forename: S
authors.initials: S
authors.lastname: Krämer
authors.forename: G M
authors.initials: GM
authors.lastname: Gershy-Damet
authors.forename: K
authors.initials: K
authors.lastname: Konan
authors.forename: A
authors.initials: A
authors.lastname: Sangare
authors.forename: L
authors.initials: L
authors.lastname: Zekeng
authors.forename: J M
authors.initials: JM
authors.lastname: Tsague
authors.forename: L
authors.initials: L
authors.lastname: Kaptue
authors.forename: J
authors.initials: J
authors.lastname: Eberle
authors.forename: L
authors.initials: L
authors.lastname: Gürtler
mesh_terms: D000956:Antigens, Viral; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D015483:HIV Antibodies / Q000097:blood*; D015658:HIV Infections / Q000175:diagnosis* / Q000821:virology; D015497:HIV-1 / Q000276:immunology*; D015498:HIV-2 / Q000276:immunology*; D006801:Humans; D011237:Predictive Value of Tests
chemical_list: D000956:Antigens, Viral; D015483:HIV Antibodies